A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure.

By R. Mehta, B. Mcdonald, F. Gabbai, M. Pahl, M. T. Pascual, A. Farkas, Robert M Kaplan. Kidney International, 2001

631 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Nephrology

View Paper: https://www.semanticscholar.org/paper/0bd888b1b6f89a8a85142f85c49666701e176b53

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Critical Care and Intensive Care Medicine

1. P. Kimmel
2. Mitchell M. Levy
3. R. Mehta
4. John A. Kellum

In Nephrology

1. John A. Kellum
2. P. Kimmel
3. Paul Eggers
4. R. Mehta
5. R. Bellomo
6. Claudio Ronco

Citations in the corpus

• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 (2017, background): “To date, five prospective RCTs have been published [497–501]; four found no significant difference in mortality [497, 498, 500, 501], whereas one found significantly higher mortality in the continuous treatment group [499]; but imbalanced randomization had led to a higher baseline severity of illnes”
• Spectrum of acute renal failure in the intensive care unit: the PICARD experience. (2004, background): “While several randomized clinical trials have been conducted in the more recent past [22–25], most have shown no benefit.”
• Diuretics, mortality, and nonrecovery of renal function in acute renal failure. (2002, neutral): “The median (with 10%90% range) doses of furosemide, bumetanide, and metolazone were 80 (20320), 10 (2-29), and 10 (5-20) mg/d, respectively.”
• Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (2004, methodology): “Studies support the equivalence of continuous and intermittent renal replacement therapies for the treatment of acute renal failure in critically ill patients (98, 99).”
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 (2007, methodology): “Concerning fluid balance management, two studies reported a significant improvement in goal achievement with continuous methods (228, 230).”
• Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group (2004, background): “Patient survival (or its reciprocal, mortality) has commonly been used as the primary end-point in clinical trials of RRT in ARF, although the timing has varied [16-18].”
• Early detection of acute renal failure by serum cystatin C. (2004, neutral): “dtd" [ ]> Acute renal failure (ARF) is common in hospitalized patients, with a mortality rate between 30% and 90”
• Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. (2006, background): “The higher in-hospital death rate in ARF discharges was probably due to severe sickness, which requires intensive care (5,7, 25 ).”
• Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. (2007, neutral): “001 SBP (mmHg; mean SD ) 116 (27) 112 (24) 119 (29) 0.”